Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Phase I Trial of High-Dose Lenalidomide and Melphalan as Conditioning for Autologous Stem Cell Transplantation in Relapsed or Refractory Multiple Myeloma.
Mark TM, Guarneri D, Forsberg P, Rossi A, Pearse R, Perry A, Pekle K, Tegnestam L, Greenberg J, Shore T, Gergis U, Mayer S, Van Besien K, Ely S, Jayabalan D, Sherbenou D, Coleman M, Niesvizky R. Mark TM, et al. Among authors: perry a. Biol Blood Marrow Transplant. 2017 Jun;23(6):930-937. doi: 10.1016/j.bbmt.2017.03.007. Epub 2017 Mar 8. Biol Blood Marrow Transplant. 2017. PMID: 28285081 Free article. Clinical Trial.
Phase II study of carfilzomib and dexamethasone therapy for newly diagnosed multiple myeloma.
Forsberg PA, Rossi AC, Boyer A, Tegnestam L, Pearse RN, Perry A, Pekle KA, Jayabalan D, Ely S, Boussi L, Sherbenou DW, Williams C, Allan JN, Coleman M, Niesvizky R, Mark TM. Forsberg PA, et al. Among authors: perry a. Am J Hematol. 2019 May;94(5):539-545. doi: 10.1002/ajh.25435. Epub 2019 Feb 25. Am J Hematol. 2019. PMID: 30740766 Free article. Clinical Trial.
Cellular Proliferation by Multiplex Immunohistochemistry Identifies High-Risk Multiple Myeloma in Newly Diagnosed, Treatment-Naive Patients.
Ely S, Forsberg P, Ouansafi I, Rossi A, Modin A, Pearse R, Pekle K, Perry A, Coleman M, Jayabalan D, Di Liberto M, Chen-Kiang S, Niesvizky R, Mark TM. Ely S, et al. Among authors: perry a. Clin Lymphoma Myeloma Leuk. 2017 Dec;17(12):825-833. doi: 10.1016/j.clml.2017.09.010. Epub 2017 Sep 20. Clin Lymphoma Myeloma Leuk. 2017. PMID: 29051077
ENA Clinical Practice Guideline Synopsis: Aggression Assessment.
Kaiser J, DeGroot D, Tucker A, Slivinski A, Camarda A, Coffey S, Dixon C, Gibson J, MacPherson-Dias R, Perry A, Slifko A, Wachtel S, Bishop-Royse J, Delao AM. Kaiser J, et al. Among authors: perry a. J Emerg Nurs. 2025 Jan;51(1):36-40. doi: 10.1016/j.jen.2024.08.007. J Emerg Nurs. 2025. PMID: 39800448 No abstract available.
VGLL-fusions define a new class of intraparenchymal CNS schwannoma.
Schmid S, Mirchia K, Tietze A, Liu I, Siewert C, Nückles J, Schittenhelm J, Behling F, Snuderl M, Hartmann C, Brandner S, Paine SML, Korshunov A, Hasselblatt M, Coras R, Epari S, Stadelmann C, Zechel S, Simon M, Wilson Y, Gianno F, Calixto-Hope GL Jr, Zherebitskiy V, Kaimaktchiev VB, Robinson L, Aldape K, Hoving EW, Tops BBJ, Perera AA, Göller P, Hernáiz Driever P, Wesseling P, Koch A, Perry A, Sahm F, Jones DTW, Capper D. Schmid S, et al. Among authors: perry a. Neuro Oncol. 2024 Dec 23:noae269. doi: 10.1093/neuonc/noae269. Online ahead of print. Neuro Oncol. 2024. PMID: 39713960
2,133 results